Skip to main content

Visit coronavirus.gov for the latest Coronavirus Disease (COVID-19) updates.

Clinical Info HIV.gov logo
In affiliation with HIV.gov

Main navigation

  • Home
  • Guidelines
  • Drug Database
  • Glossary
  • Resources
  • Contact Us
  • English
  • Español (Spanish)

Language:

  • English
  • Spanish

clinical info.hiv.gov

Offering Information on HIV/AIDS Treatment, Prevention, and Research

Interim Guidance for Covid-19 and Persons with HIV is now available.

See Guidance 

Clinical Guidelines

Federally approved medical practice guidelines for HIV/AIDS.
Guidelines 
Drug Database

Drug Database

Information on FDA-approved HIV/AIDS and opportunistic infection drugs and investigational HIV/AIDS drugs. Drugs 
Glossary

Glossary

Medical dictionary of HIV-related terms.
Glossary 
Resources

Resources

HIV-related resources from the National Institutes of Health.
Resources 

Free Mobile Apps

Download these free applications for your iOS and Android devices.
ClinicalInfo Guidelines
Guidelines
Download ClinicalInfo Guidelines app on the AppStore
Download ClinicalInfo Guidelines app on GooglePlay
ClinicalInfo Glossary
Drug database
Download ClinicalInfo Glossary app on the AppStore
Download ClinicalInfo Glossary app on GooglePlay
ClinicalInfo Drug Database
Glossary
Download ClinicalInfo Drug Database app on the AppStore
Download ClinicalInfo Drug Database app onGooglePlay

Candidiasis

  • Read more about Candidiasis

Bartonellosis

  • Read more about Bartonellosis

Bacterial Enteric

  • Read more about Bacterial Enteric

Section Review Group

  • Read more about Section Review Group

Leadership

  • Read more about Leadership

Poor CD4 Cell Recovery and Persistent Inflammation Despite Viral Suppression

  • Read more about Poor CD4 Cell Recovery and Persistent Inflammation Despite Viral Suppression

Figure 1. Recommended Immunization Schedule for Children with HIV Infection Aged 0 through 18 Years; United States, 2019

  • Read more about Figure 1. Recommended Immunization Schedule for Children with HIV Infection Aged 0 through 18 Years; United States, 2019

Table 5. Significant Drug Interactions for Drugs Used to Treat or Prevent Opportunistic Infections

  • Read more about Table 5. Significant Drug Interactions for Drugs Used to Treat or Prevent Opportunistic Infections

Table 4. Common Drugs Used for Treatment of Opportunistic Infections in HIV-Infected Children: Preparations and Major Toxicities

  • Read more about Table 4. Common Drugs Used for Treatment of Opportunistic Infections in HIV-Infected Children: Preparations and Major Toxicities

Table 3. Treatment

  • Read more about Table 3. Treatment

Pagination

  • First page « First
  • Previous page ‹ Previous
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Current page 8
  • Page 9
  • Page 10
  • Page 11
  • Page 12
  • Next page Next ›
  • Last page Last »

Connect with us

Facebook
Twitter
Instagram
Subscribe

Mobile Apps

Guidelines
Drug Database
Glossary

Footer menu

  • Home
  • About
  • News
  • Contact Us
  • Privacy Policy
  • Sponsors
  • Nondiscrimination Notice
  • Disclaimers
  • Accessibility

External links

  • HIVinfo.NIH.gov
  • HHS.gov
  • NIH.gov
  • Players & Viewers
  • HHS 508
  • HHS Privacy Policy
  • Whitehouse.gov
  • USA.gov
  • Freedom of Information Act

Provided in collaboration with NIH’s Office of AIDS Research.